Median serum NT-proBNP levels were higher in CHD+ patients (17 pmol/L (range 7–155)) compared to CHD– patients (6 pmol/L (2–23)) (p = 0.016) (Figure 2C). Here, NPPB is linked to coronary artery disorder.